Rural hospital mergers, antitrust policy, and the Ukiah case.

Autor: Blackstone EA (AUTHOR), Fuhr JP Jr. (AUTHOR)

Publikováno v: Journal of Health Politics, Policy & Law. Dec98, Vol. 23 Issue 6, p949-971. 23p.

The health and economic effects of counterfeit drugs.

Autor: Blackstone EA; Professor of Economics, Temple University, Philadelphia, PA., Fuhr JP Jr; Professor of Economics, Widener University, Philadelphia, PA., Pociask S; President, The American Consumer Institute, Washington, DC.

Publikováno v: American health & drug benefits [Am Health Drug Benefits] 2014 Jun; Vol. 7 (4), pp. 216-24.

Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety.

Autor: Blackstone EA, Fuhr JP Jr

Publikováno v: Biotechnology healthcare [Biotechnol Healthc] 2012 Spring; Vol. 9 (1), pp. 24-7.

Biopharmaceuticals: the economic equation.

Autor: Blackstone EA; Erwin A. Blackstone, PhD, is a professor of economics at Temple University in Philadelphia. Joseph P. Fuhr Jr., PhD, is a professor of economics at Widener University, in Chester, Pa., and an adjunct research professor for the Department of Health Policy, Thomas Jefferson University, in Philadelphia., Fuhr JP Jr

Publikováno v: Biotechnology healthcare [Biotechnol Healthc] 2007 Dec; Vol. 4 (6), pp. 41-5.

Generic biopharmaceutical drugs: an economic and policy analysis.

Autor: Blackstone EA, Fuhr JP Jr

Publikováno v: Biotechnology healthcare [Biotechnol Healthc] 2007 Feb; Vol. 4 (1), pp. 43-8.